Homonuclear 1H NMR and circular dichroism study of the HIV-1 Tat Eli variant

Retrovirology

Volumn 5, Issue , 2008, Pages

  Watkins, Jennifer D ^a   Campbell, Grant R ^b   Halimi, Hubert ^a   Loret, Erwann P ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; TRANSACTIVATOR PROTEIN; TRYPTOPHAN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; CONTROLLED STUDY; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR MODEL; MOLECULAR SIZE; NONHUMAN; PROTEIN FOLDING; PROTEIN PURIFICATION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID PHASE SYNTHESIS; TRANSACTIVATION; VIRAL GENETICS; CHEMICAL STRUCTURE; CHEMISTRY; NUCLEAR MAGNETIC RESONANCE; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CIRCULAR DICHROISM; HIV-1; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 53349173299     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-5-83     Document Type: Article

References (35)

1. Fisher AG Feinberg MB Josephs SF Harper ME Marselle LM Reyes G Gonda MA Aldovini A Debouk C Gallo RC The trans-activator gene of HTLV-III is essential for virus replication Nature 1986, 320:367-371. 3007995.
2. Jeang KT Xiao H Rich EA Multifaceted activities of the HIV-1 transactivator of transcription, Tat J Biol Chem 1999, 274:28837-28840. 10506122
3. Bennasser Y Jeang KT HIV-1 Tat interaction with Dicer: Requirement for RNA Retrovirology 2006, 3:95-101. 1764028 17181864
4. Ensoli B Buonaguro L Barillari G Fiorelli V Gendelman R Morgan RA Wingfield P Gallo RC Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation J Virol 1993, 67:277-287. 237361 8416373
5. Gallo RC Tat as one key to HIV-induced immune pathogenesis and Tat toxoid as an important component of a vaccine Proc Natl Acad Sci USA 1999, 96:8324-8326. 33620 10411869
6. Campbell GR Watkins JD Esquieu D Pasquier E Loret EP Spector SA The C-terminus of HIV-1 Tat modulates the extent of CD178 mediated apoptosis of T cells J Biol Chem 2005, 280:38376-38382. 16155003
7. Goldstein G HIV-1 Tat protein as a potential AIDS vaccine Nat Med 1996, 2:960-964. 8782444
8. Klase Z Donio MJ Blauvelt A Marx PA Jeang KT Smith SM A peptide-loaded dendritic cell based cytotoxic T-lymphocyte (CTL) vaccination strategy using peptides that span SIV Tat, Rev, and Env overlapping reading frames Retrovirology 2006, 3:1-6. 1360091 16398928
9. Ensoli B Fiorelli V Ensoli F Cafaro A Titti F Buttò S Monini P Magnani M Caputo A Garaci E Candidate HIV-1 Tat vaccine development: from basic science to clinical trials AIDS 2006, 20:2245-2261. 17117011
10. Opi S Peloponese JM Esquieu D Campbell G de Mareuil J Walburger A Solomiac M Gregoire C Bouveret E Yirrell DL Loret EP Tat HIV-1 primary and tertiary structures critical to immune response against non-homologous variants J Biol Chem 2002, 277:35915-35919. 12080071
11. Barre-Sinoussi F Chermann JC Rey F Nugeyre MT Chamaret S Gruest J Dauguet C Axler-Blin C Vezinet-Brun F Rouzioux C Rozenbaum W Montagnier L Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science 1983, 220:868-71. 6189183.
12. Péloponèse JM Collette Y Grégoire C Opi S Bailly C Campèse D Meurs E Olive D Loret EP Full peptide synthesis, purification, and characterization of six Tat variants J Biol Chem 1999, 274:11473-11478. 10206951
13. Kuppuswamy M Subramania T Srinivasan A Chinnadurai G Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis Nucl Acids Res 1989, 17:3551-3561. 317795 2542902
14. Péloponèse JM Grégoire C Opi S Esquieu D Sturgis J Lebrun E Meurs E Collette Y Olive D Aubertin AM Witvrow M Pannecouque C De Clercq E Bailly C Lebreton J Loret EP 1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein C R Acad Sci III 2000, 323(10):883-894. 11098404
15. Grégoire C Péloponèse JM Esquieu D Opi S Campbell G Solomiac M Lebrun E Lebreton J Loret EP Homonuclear 1H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein Biopolymers 2001, 62:324-335. 11857271
16. Shojania S O'Neil JD HIV-1 Tat is a natively unfolded protein: The solution conformation and dynamics of reduced HIV-1 Tat-(1-72) by NMR spectroscopy J Biol Chem 2006, 281:8347-8356. 16423825
17. Alizon M Wain-Hobson S Montagnier L Sonigo P Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients Cell 1986, 46:63-74. 2424612
18. Johnson WC Circular dichroism and its empirical application to biopolymers Methods Biochem Anal 1985, 31:61-163. 3894885
19. Johnson WC Protein secondary structure and circular dichroism: A practical guide Proteins 1990, 7:205-214. 2194218
20. Frankel AD Bredt DS Pabo CO Tat protein from human immunodeficiency virus forms a metal-linked dimmer Science 1988, 240:70-73. 2832944
21. Huang HW Wang KT Structural characterization of the metal binding site in the cysteine-rich region of HIV-1 Tat protein Biochem Biophys Res Commun 1996, 227:615-621. 8878561
22. Misumi S Takamune N Ohtsubo Y Waniguchi K Shoji S Zn2+ binding to cysteine-rich domain of extracellular human immunodeficiency virus type 1 Tat protein is associated with Tat protein-induced apoptosis AIDS Res Hum Retroviruses 2004, 20:297-304. 15117453
23. Nilges M Clore GM Gronenborn AM Determination of three-dimensional structures of proteins from interproton distance data by dynamical simulated annealing from a random array of atoms. Circumventing problems associated with folding FEBS Lett 1988, 239:129-136. 3181419
24. Jeang KT Berkhout B Dropulic B Effects of integration and replication on transcription of the HIV-1 long terminal repeat J Biol Chem 1993, 268:24940-24949. 8227056
25. Smith SM Pentlicky S Klase Z Singh M Neuveut C Lu CY Reitz MS Jr Yarchoan R Marx PA Jeang KT An in vivo replication-important function in the second coding exon of Tat is constrained against mutation despite cytotoxic T lymphocyte selection J Biol Chem 2003, 278:44816-44825. 12947089
26. Bayer P Kraft M Ejchart A Westendorp M Frank R Rosch P Structural studies of HIV-1 Tat protein J Mol Biol 1995, 247:529-535. 7723010
27. Campbell GR Senkaali D Watkins J Esquieu D Opi S Yirrel DL Kaleebu P Loret EP Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties Vaccine 2007, 25:8441-8447. 17997200
28. Senkaali D Kebba A Shafer LA Campbell GR Loret EP Paal Van Der L Grosskurth H Yirrell D Kaleebu P Tat-specific binding IgG and disease progression in HIV type 1-infected Ugandans AIDS Res Hum Retroviruses 2008, 24:587-594. 18366309
29. Barany G Merrifield RB Solid phase peptide synthesis The Peptide: Analysis, Synthesis, Biology New York, NY: Academic Press Gross E, Meinhofer J 1980, 2:1-284.
30. Bohan CA Kashanchi F Ensoli B Buonaguro L Boris-Lawrie K Brady JN Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro Gene Expr 1992, 2:391-408. 1282057
31. Clavel F Charneau P Fusion from without directed by human immunodeficiency virus particles J Virol 1994, 68:1179-1185. 236557 8289347
32. Manavalan P Johnson WC Variable selection method improves the prediction of protein secondary structure from circular dichroism spectra Anal Biochem 1987, 167:76-85. 3434802
33. Braunschweiler L Ernst RR Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy J Magn Reson 1983, 53;521-528.
34. Bax A Davis DG MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy J Magn Reson 1985, 65:355-360.
35. Macura S Huang Y Suter D Ernst RR Two-Dimensional Chemical Exchange and Cross-Relaxation Spectroscopy of Coupled Nuclear Spins J Magn Reson 1981, 43:259-228.